SOURCES SOUGHT
A -- United States Renal Data System Coordinating Center
- Notice Date
- 4/19/2013
- Notice Type
- Sources Sought
- NAICS
- 541712
— Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Library of Medicine, 6707 Democracy Blvd., Suite 105, Bethesda, Maryland, 20894, United States
- ZIP Code
- 20894
- Solicitation Number
- NIHLM2013725
- Archive Date
- 5/17/2013
- Point of Contact
- April N. Merriwether, Phone: 3014021517, Ed Kostolansky, Phone: 301-594-4758
- E-Mail Address
-
merriwetheran@nlm.nih.gov, Edward.Kostolansky@nih.gov
(merriwetheran@nlm.nih.gov, Edward.Kostolansky@nih.gov)
- Small Business Set-Aside
- N/A
- Description
- This is a Small Business Sources Sought notice. This is NOT a solicitation for proposals, proposal abstracts, or quotations. The purpose of this notice is to obtain information regarding: (1) the availability and capability of qualified small business sources; (2) whether they are small businesses; HUBZone small businesses; service-disabled, veteran-owned small businesses; 8(a) small businesses; veteran-owned small businesses; woman-owned small businesses; or small disadvantaged businesses; and (3) their size classification relative to the North American Industry Classification System (NAICS) code for the proposed acquisition. Your responses to the information requested will assist the Government in determining the appropriate acquisition method, including whether a set-aside is possible. An organization that is not considered a small business under the applicable NAICS code should not submit a response to this notice. Background. The National Institute of Diabetes and Digestive and Kidney Diseases has a requirement for a Coordinating Center (CC) for the United States Renal Data System (USRDS). End stage renal disease (ESRD) is a major public health problem, significant morbidity and mortality in the U.S. population, and leading to enormous financial and personal costs. A similar problem is encountered in other Western countries. Over the past 15 years, studies using the USRDS data base have shown that, while the incidence rate of ESRD has stabilized, the number of new patients continued to increase due to population growth and aging. Mortality from ESRD exceeds 20 percent per year. Other studies have found that certain racial/ethnic groups, especially Blacks and Native Americans, are disproportionately represented in the ESRD patient population, and seem to be particularly vulnerable to certain disease entities such as diabetes mellitus and hypertension that ultimately lead to chronic kidney disease (CKD) and ESRD. In the past, although the CMS (formally the Health Care Financing Administration) maintained a data collection system, gathering information on Medicare beneficiary‑specific entitlement, demographic, cost, and utilization data, and Medicare facility‑specific certification data, a comprehensive ESRD database was not originally available. Specifically, detailed information, including both clinical and laboratory information on the etiology of the underlying renal disease, method of treatment, and overall outcomes for the ESRD‑Medicare patient population was not available. For these reasons, the USRDS was created in May 1988 to collect and analyze information on the incidence, prevalence, morbidity, and mortality of ESRD in the U.S. In the second phase of the USRDS project, the contract for the Coordinating Center was awarded. The third phase of the USRDS project represented a change in structure for the USRDS. The work of the USRDS was decentralized and spread across five separate contracts. The contracts were for the Coordinating Center, for data management of the data base and the production of the Annual Data Reports (ADRs); Cardiovascular Special Studies Center; Economic Special Studies Center; Quality of Life/Rehabilitation Special Studies Center; and the Nutrition Special Studies Center. The fourth phase was a continuation of the structure put in place during the third phase; however, there was no Economic Special Studies Center. All of the economic analyses were incorporated into the Coordinating Center and Special Study Center scopes of work. Since the inception of the USRDS the CC, with the approval of the NIDDK, has undertaken several studies, including existing data analyses, and special studies; has provided data to several hundred investigators; and has produced yearly annual data reports (ADR) since 1989. By using the CMS Medicare files, it is estimated that the USRDS database contains information on nearly 100 percent of the ESRD population since the early 1980s. Data from the 2012 ADR indicates that the 2010 incidence of ESRD was 116,946, with a December 31, 2010 point prevalence of 594,374. Detailed information on patients undergoing various modalities of therapy, including disease categories, morbidity and mortality are available in the data base and presented in the annual ADRs and the internet at http://www.usrds.org. During the history of USRDS, it has provided significant benefits to the U.S. nephrology and renal transplant communities, and the ESRD population at large. Some of the accomplishments include the following: Construction of Database, Existing Data Studies, Data Provision to the Community, Annual Data Reports, In-Depth Analyses, Special Studies, and analyses of the Chronic Kidney Disease Population. Purpose and Objectives. The contractor will be required to serve as the Coordinating Center (CC) for the United States Renal Data System (USRDS). The CC, in collaboration with the NIH and the Centers for Medicare and Medicaid Services (CMS), provides the biostatistical, epidemiological, data management and analytical expertise necessary to maintain and update the existing USRDS database. The CC also coordinates, scientifically manages, develops and expands the database; prepares and releases subset(s) of the database to support investigator-initiated research; publishes papers and reports of scientific findings based on USRDS data; and provides data to support research performed by the Special Studies Center(s) (SSCs). This phase of the USRDS project will have the following major objectives: •a. * Characterization of the ESRD patient population, including the distribution of demographic variables or attributes, and the geographic distribution of patients across the several modalities of ESRD treatment and the serial changes over time. •b. * Description of the prevalence and incidence rates of kidney diseases of differing etiologies that lead to ESRD. •c. * Investigations of the relationships between various modalities of treatment, disease, and patient group categories. •d. * Support of independent investigator-initiated research; emphasis on 2-Hour Request, Greater Than 2-Hour Requests, and Investigator-Initiated Research Support. •e. * Provision of analysis datasets and appropriately selected national samples of ESRDS patients and USRDS database data to support special studies research by the SSC. •f. * Identification of problems and opportunities for focused investigation. •g. * Design and implementation of existing data studies and special data collection studies, leading to conclusions that may be generalized for improvement in the health of the ESRD population. •h. * Conduct of cost effectiveness studies and other economic studies of ESRD, in areas of significant interest to the NIDDK and CMS. Anticipated Period of Performance. The anticipated period of performance of this project is five years. Capability statement/information sought. Information submitted should be relevant and specific in the technical area under consideration. Information provided must address experience outlining previous similar projects. Respondents should identify specific personnel, including names, professional qualifications, specific experience in the work requested, and their availability. Corporate and management capability must also be addressed. All capability statements must provide the respondents' DUNS number, organization name, address, point of contact, and size and type of business pursuant to the applicable NAICS code. Capability statements must be received no later than 12:00pm local time on May 02, 2013. Questions may be directed to April Merriwether at merriwetheran@mail.nih.gov. Electronic capability statements will not be accepted. Respondents must submit their capability statements in three copies to the following address: Ms. April Merriwether NIDDK Acquisitions Branch Office of Acquisitions, NLM 2 Democracy Plaza, Suite 700W 6707 Democracy Boulevard, MSC 5455 Bethesda, Maryland 20892-5455 If hand-delivered or using delivery service, use Bethesda, Maryland 20817 Disclaimer and Important Notes. This notice does not obligate the Government to award a contract or otherwise pay for the information provided in response. The Government reserves the right to use information provided by respondents for any purpose deemed necessary and legally appropriate. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to determine the organization's qualifications to perform the work. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provided feedback to respondents with respect to any information submitted. After a review of the responses received, a pre-solicitation synopsis and solicitation may be published in Federal business Opportunities. However, responses to this notice will not be considered adequate responses to a solicitation. Confidentiality. No proprietary, classified, confidential, or sensitive information should be included in your response. The Government reserves the right to use any non-proprietary technical information in any resultant solicitation(s).
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/OAM/NIHLM2013725/listing.html)
- Record
- SN03041432-W 20130421/130419234715-eb8ffd77c1b37486d1494d47ca823621 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |